Teva wins bidding war for Germany’s ratiopharm, beating out Pfizer and Actavis. The purchase gives it the second largest share in the fast-evolving, rough-and-tumble German generics market, as well as a stronger presence in Europe and some emerging markets.
The House releases some details of its updated health care reform package, including how to close the Medicare Part D "donut hole."
The National Institutes of Health announced that it is building a voluntary registry of genetic tests that will go online in 2011 as a resource for patients, health care providers, third-party payers and researchers who have no way of finding and comparing tests in this largely unregulated field.
Pfizer dismisses its eight-year suit alleging Lilly's Cialis infringes its Viagra patent. The move was not unexpected since the U.S. Patent and Trademark Office's Board of Patent Appeals rejected Pfizer's patent claim last month.
